Back to search

Article

Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer (NSCLC)

2023-02-20

Abstract excerpt

<title>Abstract</title> <p>Abnormally high expression of lysine-specific demethylase 1A (LSD1) and DCN1 plays a vital role in the occurrence, development, and poor prognosis of non-small cell lung cancer (NSCLC). Accumulating evidence has shown that the development of small-molecule inhibitors dually targeting LSD1 and the UBC12-DCN1 interaction probably have therapeutic promise for cancer therapy. This work repo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d5e68a31-b529-5d30-9c18-b47325e4730b
DOI
10.21203/rs.3.rs-2593334/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovery of WS-384, a first-in-class dual LSD1 and DCN1-UBC12 protein-protein interaction inhibitor for the treatment of non-small cell lung cancer (NSCLC)DOI 10.21203/rs.3.rs-2593334/v1
Select a neighboring publication to make it the new centre.